Zoladex Depot (3.6Mg) Injection

Zoladex Depot (3.6 mg) Injection is a prescription medication containing goserelin, a synthetic hormone that belongs to a group of drugs called LHRH agonists (Luteinizing Hormone-Releasing Hormone agonists). It is widely used in the treatment of hormone-sensitive conditions such as prostate cancer, breast cancer, and certain gynecological disorders.

What is Zoladex Depot 3.6 mg Injection?

Zoladex Depot 3.6 mg is a long-acting implant injection administered under the skin, usually in the abdomen. It works by reducing the production of hormones like testosterone in men and estrogen in women, which helps slow or stop the growth of hormone-dependent tumors.

Uses of Zoladex Depot Injection

• Treatment of prostate cancer
• Management of breast cancer
• Treatment of endometriosis
• Control of uterine fibroids
• Used in assisted reproduction (IVF) to regulate hormones
• Management of precocious puberty (early puberty)

Benefits of Zoladex Depot 3.6 mg

• Helps shrink or slow tumor growth
• Reduces hormone levels effectively
• Provides long-lasting action (usually 28 days per dose)
• Minimizes need for frequent dosing
• Helps relieve symptoms like pain and abnormal bleeding (in gynecological conditions)

How Zoladex Works

Zoladex acts on the pituitary gland to initially increase, then significantly decrease hormone production. This process lowers testosterone in men and estrogen in women, which is essential for controlling hormone-dependent diseases.

Side Effects of Zoladex Depot Injection

Like all medications, Zoladex may cause side effects. Common and serious ones include:

Common Side Effects

• Hot flashes
• Sweating
• Headache
• Mood changes
• Decreased libido
• Injection site pain

Serious Side Effects

• Bone thinning (osteoporosis)
• Increased blood sugar levels
• Cardiovascular issues
• Allergic reactions (rare)
• Tumor flare (temporary worsening of symptoms at start)

Precautions & Warnings

• Not recommended during pregnancy
• Use caution in patients with diabetes or heart disease
• Long-term use may affect bone density
• Regular monitoring by a doctor is required

Dosage & Administration

• Typically given once every 28 days
• Administered by a healthcare professional
• Do not self-inject unless instructed